Live Breaking News & Updates on Ernesto Salegio

Stay updated with breaking news from Ernesto salegio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and Translational Development Team to Support Gene and Stem Cell Therapy Partners


(1)
IRVINE, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that Ernesto Salegio, PhD will join the Company as Vice President, Segment Leader Translational and Pre-Clinical Research as part of ClearPoint s Biologics and Drug Delivery team on March 1, 2021. Dr. Salegio brings over 19 years of experience in translational neuroscience with direct pre-clinical central nervous system (CNS) expertise in the delivery of therapeutics to the brain and spinal cord, including over 16 years of gene therapy experience working with adeno-associated viral vectors (AAV).
ClearPoint Neuro s Biologics and Drug Delivery team was established in 2020 to provide turn-key medical device innovation, therapy delivery development and clinical services customized for both pharmaceutical and academic partners working on gene and stem cell therapies to the brain. ....

United States , Clearpoint Biologics , Kostenloser Wertpapierhandel , Jeremy Stigall , Ernesto Salegio , Company As Vice , Biologics Drug Delivery Development , Company Clearpoint Neuro Navigation System , Clearpoint Neuro Inc , Exchange Commission , Company Annual Report On Form , Clinical Research , Applications Of The Company , Company Quarterly Report On Form , Company Smartflow , Point Neuro , Vice President , Segment Leader Translational , Preclinical Research , Drug Delivery , Clearpoint Neuro Navigation System , Annual Report , Quarterly Report , ஒன்றுபட்டது மாநிலங்களில் , தெளிவான புள்ளி உயிரியல் , ஜெர்மி ஸ்டிகல்ல் ,